Marshall Wace
ICAD

Marshall Wace’s iCAD Inc ICAD Stock Holding History

Marshall Wace’s Portfolio ICAD Stock Details ICAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-13,669
Closed -$62K – 3621
2022
Q1 		$62K Sell
13,669
-18,024
-57% -$90.7K ﹤0.01% 3234
2021
Q4 		$229K Buy
+31,693
New +$283K ﹤0.01% 3110

Other funds holding ICAD

GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
GCA
Greenwood Capital Associates Greenwood, South Carolina $908M AUM 24.22% 1-Year Est. Return

Marshall Wace's ICAD Position: Q2 2022 in Review

Marshall Wace sold out of iCAD Inc (ICAD) in Q2 2022, closing a stake of 13,669 shares — an estimated $62K sold.

Marshall Wace first reported a position in ICAD in Q4 2021 and held it in 2 quarters. The position peaked at $229K in Q4 2021. 67 funds tracked by Wall St. Rank hold ICAD as of Q2 2022.

  • Marshall Wace reported no remaining iCAD Inc position as of Q2 2022 after selling out during the quarter.
  • Marshall Wace sold 13,669 iCAD Inc shares in Q2 2022, an estimated $62K.
  • Marshall Wace first reported a position in iCAD Inc in Q4 2021 and held it in 2 quarters.
  • Marshall Wace's iCAD Inc position peaked at $229K in Q4 2021.
  • 67 funds tracked by Wall St. Rank held iCAD Inc as of Q2 2022.

Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.